Skip to main content

Corient Private Wealth LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1948780 MIAMI, FL

Position in HALO

as of Jun 30, 2026 · filed Aug 27, 2026
Position Value
$14,649,482
+$2,325,576 QoQ
Shares Held
187,166
-1.8% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#97
of 664 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 52% Shared 1% None 47%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Corient Private Wealth LLC holds $246,096,400 across 122 Biotechnology names. HALO ranks #3 (6.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 HALO
Halozyme Therapeutics, Inc.
This page
187,166 $14,649,482

All Filings in HALO

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,649,482 187,166
2026-03-31 $12,323,906 190,684
2025-12-31 $13,231,180 196,600
2025-09-30 $871,351 11,881
2025-06-30 $417,720 8,030
2025-03-31 $625,273 9,799
2024-12-31 $276,293 5,779
2024-09-30 $1,158,708 20,243
2024-06-30 $1,447,910 27,653
2024-03-31 $895,651 22,017
2023-12-31 $808,721 21,881
2023-09-30 $713,385 18,675
2023-06-30 $598,762 16,600
2022-12-31 $283,133 4,976